Identification and application of an aptamer targeting papillary thyroid carcinoma using tissue-SELEX

W Zhong, Y Pu, W Tan, J Liu, J Liao, B Liu… - Analytical …, 2019 - ACS Publications
thyroid carcinoma and a normal thyroid gland. TC-6 could specifically target intracellular
components of papillary thyroid … could distinguish thyroid carcinoma from other benign thyroid

Anaplastic thyroid carcinoma: an overview

WR Cornett, AK Sharma, TA Day, MS Richardson… - Current oncology …, 2007 - Springer
Thyroid cancer is an uncommon malignancy that accounts for roughly 1… thyroid cancers,
they represent over half of thyroid cancer-related deaths. The relative rarity of anaplastic thyroid

Postoperative Surveillance of Differentiated Thyroid Carcinoma: Rationale, Techniques, and Controversies1

NA Johnson, ME Tublin - Radiology, 2008 - pubs.rsna.org
… our understanding of the biology of thyroid carcinoma; aggressive surgery is … thyroid carcinoma
may help differentiate between typical indolent disease and aggressive thyroid carcinoma

Management of thyroid carcinoma with radioactive 131I

SB Paryani, RJ Chobe, W Scott, J Wells Jr… - International Journal of …, 1996 - Elsevier
… confined to the thyroid, we recommend following patients with annual thyroid scans and serum
… the thyroid, we recommend routine thyroid ablation of 100–150 mCi of radioactive 131 I. …

Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up

P Carcoforo, M Portinari, L Feggi, S Panareo… - Surgery, 2014 - Elsevier
… Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, accounting for
80% of all such tumors. The optimal strategy for the treatment of patients with PTC combines…

Lenvatinib compared with sorafenib as a first-line treatment for radioactive iodine-refractory, progressive, differentiated thyroid carcinoma: real-world outcomes in a …

M Kim, M Jin, MJ Jeon, EY Kim, DY Shin, DJ Lim… - Thyroid, 2023 - liebertpub.com
… The overall survival rate of differentiated thyroid carcinoma (DTC) is reported to be 98% at 5
… as ALK, NTRK, and RET gene fusions and selectively inhibit cancer cell growth with minimal …

Oncologic outcomes after completion thyroidectomy for patients with well-differentiated thyroid carcinoma

BR Untch, FL Palmer, I Ganly, SG Patel… - Annals of surgical …, 2014 - Springer
… The purpose of this study was to identify the indications for selective completion … Recently,
our institution published the results of patients with resected T1 and T2, N0 thyroid carcinomas

Treatment of lateral neck papillary thyroid carcinoma recurrence after selective lateral neck dissection

V Strajina, BM Dy, TJ McKenzie, Z Al-Hilli, RA Lee… - Surgery, 2019 - Elsevier
… Lateral neck recurrence after selective neck dissection for papillary thyroid carcinoma may
be difficult to control. Both ethanol ablation and surgery can achieve disease control in the …

Clinical utility of cabozantinib in the treatment of locally advanced or metastatic differentiated thyroid carcinoma: Patient selection and reported outcomes

L Roof, JL Geiger - Cancer Management and Research, 2023 - Taylor & Francis
… of various highly selective inhibitors targeting specific driver mutations in different forms of
thyroid cancer. Cabozantinib is unique in its profile of targeting medullary thyroid cancer RET …

Discovery of targeting peptides for selective therapy of medullary thyroid carcinoma

M Böckmann, M Drosten… - The Journal of Gene …, 2005 - Wiley Online Library
… We initially analyzed adenoviral receptor expression in human medullary thyroid carcinoma
(MTC) cells. MTC cell-specific peptides were isolated by biopanning a phage display …